Prevalence of HIV and STDs in a Dutch transgender population: TITAN- study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21280

Enrollment

300

Registered

2020-12-09

Start date

2020-08-12

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV and STDs (Hepatitis B and C, Syphilis, Chlamydia and Gonorrhea)

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients are included when: - Diagnosed with gender-dysphoria according to DSM IV/V criteria - Treated at the transgender outpatient clinic of the VUMC - Age = 18 years - Informed consent obtained - >12 months hormonal therapy - Speaking Dutch language

Exclusion criteria

Exclusion criteria: Patients are excluded when: - Age < 18 years - No informed consent obtained - If the patient does not want to know the HIV or STD test results.

Design outcomes

Primary

Measure	Time frame
Prevalence of HIV/STD diagnoses (by anatomic site)	—

Secondary

Measure	Time frame
Determinants of HIV and STD infections	—

Contacts

Public ContactMartin den Heijer

Amsterdam UMC- location VUMC

m.denheijer@amsterdamumc.nl0204444444

Outcome results